glutamic acid has been researched along with pinocembrin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, GH; Gao, M; Hu, JJ; Liu, GT; Liu, QS; Zhang, WC | 1 |
| Abdel Salam, RM; Attia, AS; Kenawy, SA; Saad, MA | 1 |
2 other study(ies) available for glutamic acid and pinocembrin
| Article | Year |
|---|---|
Pinocembrin prevents glutamate-induced apoptosis in SH-SY5Y neuronal cells via decrease of bax/bcl-2 ratio.
Topics: Apoptosis; bcl-2-Associated X Protein; Calcium; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Flavanones; Gene Expression Regulation; Glutamic Acid; Humans; L-Lactate Dehydrogenase; Neuroblastoma; Proto-Oncogene Proteins c-bcl-2; RNA, Messenger; Tumor Suppressor Protein p53 | 2008 |
Pinocembrin attenuates hippocampal inflammation, oxidative perturbations and apoptosis in a rat model of global cerebral ischemia reperfusion.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Apoptosis; Biomarkers; Brain Ischemia; Carotid Stenosis; Cerebral Infarction; Flavanones; Glutamic Acid; Glutathione; Hippocampus; L-Lactate Dehydrogenase; Male; Oxidative Stress; Rats; Rats, Wistar; Reperfusion Injury | 2015 |